• OPEN AN ACCOUNT
Indian Indices
Sensex
80,238.85 -1,048.34
( -1.29%)
Global Indices
Nasdaq
48,904.78 -73.14
(-0.15%)
Dow Jones
6,863.50 -36.75
(-0.53%)
Hang Seng
56,282.78 -1,774.46
(-3.06%)
Nikkei 225
10,473.49 -306.62
(-2.84%)
Forex
USD-INR
91.06 0.13
(0.14%)
EUR-INR
107.55 0.22
(0.20%)
GBP-INR
122.70 -0.27
(-0.22%)
JPY-INR
0.58 0.00
(0.12%)

EQUITY - MARKET SCREENER

Ranjeet Mechatronics Ltd
Industry :  Engineering
BSE Code
ISIN Demat
Book Value()
541945
INE01A501027
5.256175
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
38.53
26.2
EPS(TTM)
Face Value()
Div & Yield %
0.17
5
0
 

Zydus enters into licensing and commercialization agreement with RK Pharma Inc.
Nov 26,2025
Zydus Lifesciences has entered into an exclusive licensing and commercialization agreement with RK Pharma Inc of the US for a novel sterile injectable 505(b)(2) oncology supportive care product for the US market.

Under the terms of this agreement, RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US.

The product, developed under the 505(b)(2) pathway, is expected to be filed in 2026 and will provide a formulation that is intended to provide reduced dosing error and enhanced compliance of healthcare professionals.